Enjoy complimentary customisation on priority with our Enterprise License!
The shingles vaccine market size has the potential to grow by USD 1.08 billion during 2020-2024, and the market’s growth momentum will accelerate during the forecast period.
This report provides a detailed analysis of the market by type (recombinant vaccines and live-attenuated vaccines) and geography (Asia, Europe, North America, and ROW). Also, the report analyzes the market’s competitive landscape and offers information on several market vendors, including CanSino Biologics Inc., Curevo Inc., GeneOne Life Science Inc., GlaxoSmithKline Plc, Merck & Co. Inc., SK Bioscience, and Vaccitech Ltd.
The shingles vaccine market is concentrated and dominated by large pharmaceutical vendors that offer highly effective and safe vaccines. SK Bioscience and Vaccitech Ltd. are some of the major market participants. Although the high incidence and prevalence of shingles will offer immense growth opportunities, the side effects of shingles vaccines will challenge the growth of the market participants. To make the most of the opportunities, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
To help clients improve their market position, this shingles vaccine market forecast report provides a detailed analysis of the market leaders and offers information on the competencies and capacities of these companies. The report also covers details on the market’s competitive landscape and offers information on the products offered by various companies. Moreover, this shingles vaccine market analysis report also provides information on the upcoming trends and challenges that will influence market growth. This will help companies create strategies to make the most of future growth opportunities.
This report provides information on the production, sustainability, and prospects of several leading companies, including:
North America was the largest shingles vaccine market in 2019, and the region will offer several growth opportunities to market vendors during the forecast period. The increasing number of immunization programs and the strong prevalence of shingles will significantly influence shingles vaccine market growth in this region.
Over 85% of the market’s growth will originate from North America during the forecast period. The US is a key market for the shingles vaccine in North America. However, market growth in this region will be slower than the growth of the market in Asia and Europe.
Recombinant vaccines depend on the capacity of one or several defined antigens to induce immunity against the pathogens. They are administered in the presence of adjuvants or harmless bacterial/viral vectors. The high efficacy and safety of recombinant vaccines is expected to boost the adoption of shingles vaccines during the forecast period.
Market growth in this segment will be faster than the growth of the market in the live-attenuated vaccines segment. This report provides an accurate prediction of the contribution of all the segments to the growth of the shingles vaccine market size.
The high incidence and prevalence of shingles will be a significant factor in driving the growth of the shingles vaccine market. The incidences of herpes zoster, also known as shingles, have increased rapidly over the past few decades. Shingles cause painful blistering rashes and can result in serious complications such as painful postherpetic neuralgia. The middle-aged adult population is more susceptible to shingles. It can re-occur several times during the lifetime of an individual. Hence, with increasing incidences and prevalence of shingles across the world, the demand for shingles vaccines is also expected to grow during the forecast period.
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Type
Customer landscape
Geographic Landscape
Drivers, Challenges, and Trends
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.